Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for advanced gastric cancer
ChiCTR-TRC-10000873Phase 2Completed
- Sponsor
- Mainluck Pharmaceuticals
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tegafur, cisplatin and fluorouracil in gastric adenocarcinoma (2 arms), sponsored by Mainluck Pharmaceuticals. Primary endpoints: Overall response rate and Time to progression. Started Sep 2008; status: completed.
02
Drugs
tegafurcisplatinfluorouracil
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-10000873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000873.